Phibro Animal Health CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Phibro Animal Health Corporation announced significant revenue and profit increases for fiscal year 2025, largely propelled by its strategic acquisition of Zoetis's medicated feed additive portfolio.
NASDAQ
10-K: Phibro Animal Health Corporation Reports Fiscal Year 2024 Results, Outlines Strategic Initiatives
Phibro Animal Health Corporation's 10-K filing details its financial performance for fiscal year 2024, highlighting growth in animal health and strategic moves amidst industry challenges.